Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950142-16-003743
Filing Date
2016-05-17
Accepted
2016-05-17 16:44:56
Documents
2
Group Members
AISLING CAPITAL II, LPAISLING CAPITAL PARTNERS, LLCAISLING CAPITAL PARTNERS, LPANDREW SCHIFFDENNIS PURCELLSEACHAID PHARMACEUTICALS LLCSTEVE ELMS

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G eh1600617_13g-cidara.htm SC 13G 208801
2 EXHIBIT 99.1 eh1600617_ex9901.htm EX-99.1 19882
  Complete submission text file 0000950142-16-003743.txt   230455
Mailing Address 88 SEVENTH AVE 30TH FL NEW YORK NY 10106
Business Address 88 SEVENTH AVE 30TH FL NEW YORK NY 10106
Aisling Capital II LP (Filed by) CIK: 0001350778 (see all company filings)

EIN.: 000000000
Type: SC 13G

Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Subject) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88806 | Film No.: 161658050
SIC: 2836 Biological Products, (No Diagnostic Substances)